News Shortcuts from other journals

Debate continues over implantable cardioverter defibrillators in hypertrophic cardiomyopathy

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7613.229-a (Published 02 August 2007) Cite this as: BMJ 2007;335:229

Hypertrophic cardiomyopathy is a highly variable disease that is often benign but can be lethal. Implantable cardioverter defibrillators reduce the risk of lethal arrhythmias, but not everyone needs one, and selecting the patients most likely to benefit remains a challenge. In one …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe